★ Daily Intelligence Briefings (DIBs)⦁ Theme TrackerBiotechnology & HealthcareⓁ Gene EditingMarkets CRISPR Closing in on First US Product Launch, Latest Data Shows Treatment 100% Effective After Three Years A decade after its discovery, an authorization of CRISPR drugs to be marketed in the US may only be a…McAlinden Research PartnersJuly 11, 2022
